PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

rifampin

Verify with FDA → · CMS NADAC pricing →

Brand names: Rifadin

Rifamycin Antibiotic Rx

Rifampin is an antibiotic medicine. It fights bacteria in your body to treat infections.

Drug Shortage Alert

rifampin is currently listed as in shortage by the FDA. Affected manufacturer: Sanofi-Aventis U.S. LLC. Status: Available.

View all drug shortages →

Drug Pricing (NADAC)

Generic Price

$0.60/unit

Generic Available

Yes (6 manufacturers)

Pricing data from NADAC (CMS), effective December 18, 2024. Compare all drug costs →

What it does

Rifampin treats tuberculosis (TB) and helps eliminate the bacteria that cause meningitis from your nose and throat.

Common side effects

Heartburn, Upset stomach, Loss of appetite

Key warnings

Rifampin can cause liver problems.

How It Works

Rifampin works by stopping bacteria from growing and multiplying. It does this by blocking a key enzyme that the bacteria need to make proteins. This helps your body fight off the infection.

How to Take It

Take rifampin by mouth or through an IV. If taking it by mouth, take it once a day, either 1 hour before or 2 hours after a meal. Always take it with a full glass of water. Adults usually take 10 mg/kg, up to 600 mg per day. Children usually take 10-20 mg/kg, up to 600 mg per day.

Pregnancy & Breastfeeding

Tell your doctor if you are pregnant or plan to become pregnant. Rifampin can make birth control pills less effective, so use other forms of birth control. Talk to your doctor if you are breastfeeding.

Missed Dose

If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule.

Storage

Store rifampin at room temperature, away from heat and light.

Side Effects (from patient reports)

Based on 7,405 FDA adverse event reports.

Drug Ineffective
1,468
Off Label Use
1,107
Drug Interaction
970
Drug Reaction With Eosinophilia And Systemic Symptoms
727
Nausea
628
Condition Aggravated
550
Pyrexia
541
Product Use In Unapproved Indication
533
Vomiting
444
Drug Resistance
437

FDA Adverse Event Report Analysis

Detailed analysis of 13,451 reports from the FDA Adverse Event Reporting System (FAERS). Reports span 2004–2025.

Total Reports

13,451

Death-Related Reports

1,383

Hospitalization Reports

5,402

Top Indication

Product Used For Unknown Indication

Gender Distribution

Female 6,022 (50%)
Male 6,092 (50%)

Age Distribution

0–17 1,065
18–44 2,935
45–64 2,796
65–74 1,886
75+ 1,576

Most Reported Adverse Reactions (FAERS)

# Reaction Reports
1 DRUG INEFFECTIVE 1,468
2 OFF LABEL USE 1,107
3 DRUG INTERACTION 970
4 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 727
5 NAUSEA 628
6 CONDITION AGGRAVATED 550
7 PYREXIA 541
8 PRODUCT USE IN UNAPPROVED INDICATION 533
9 VOMITING 444
10 DRUG RESISTANCE 437
11 ACUTE KIDNEY INJURY 396
12 DRUG INTOLERANCE 391
13 DYSPNOEA 380
14 DIARRHOEA 378
15 RASH 378

Reactions in Death Reports

DRUG INEFFECTIVE 313
DEATH 185
OFF LABEL USE 124
MULTIPLE ORGAN DYSFUNCTION SYNDROME 76
RESPIRATORY FAILURE 69
ACUTE KIDNEY INJURY 63
SEPSIS 63
DRUG INTERACTION 60
CONDITION AGGRAVATED 57
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 57

Reactions in Hospitalization Reports

DRUG INEFFECTIVE 616
DRUG INTERACTION 482
OFF LABEL USE 416
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 404
PYREXIA 336
NAUSEA 282
ACUTE KIDNEY INJURY 266
VOMITING 239
CONDITION AGGRAVATED 228
DIARRHOEA 185

Source: FDA FAERS (Adverse Event Reporting System) FDA FAERS (Adverse Event Reporting System) Reports are voluntary and do not establish causation

Serious Warnings

Rifampin can cause liver problems. Tell your doctor right away if you have yellowing of the skin or eyes, dark urine, or stomach pain. Rifampin can also cause blood problems. Tell your doctor if you have unusual bleeding or bruising.

Known Drug Interactions

Table 1: Drug Interactions with Rifampin that Affect Concomitant Drug Concentrations Administered with rifampin 600 mg daily, unless otherwise specified Drug or Drug Class and Prevention or Management Clinical Effect AUC = area under the time-concentration curve Antiretrovirals Prevention or Management: Concomitant use is contraindicated (see CONTRAINDICATIONS ) Atazanavir Decrease AUC by 72% Darunavir Rifampin dosage used concomitantly with the drug(s) is not specified in the proposed package insert.

Mechanism: Rifampin reduces the amount of darunavir in your body, which can prevent the medicine from controlling the virus.

What to do: This combination is not allowed and should be avoided.

Antimycobacterials: rifabutin rifampin , Strong inducer of CYP3Aand P-gp, and inducer of UGT1A1. rifapentine ↓ BIC ↓ TAF Coadministration with rifampin is contraindicated due to the effect of rifampin on the BIC component of BIKTARVY [see Contraindications (4) ] .

Mechanism: Rifampin speeds up how fast your body breaks down the HIV medicine, which makes the HIV medicine less effective. This can cause the HIV virus to become harder to treat.

What to do: Do not take these two medications together. Your doctor will need to find a different antibiotic that does not interfere with your HIV treatment.

Antimycobacterials: Rifampin ↓ glecaprevir ↓ pibrentasvir Coadministration is contraindicated because of potential loss of therapeutic effect [see Contraindications ( 4 ) ] .

Mechanism: Rifampin lowers the levels of the hepatitis C medicine in your body. This makes the treatment less effective and may prevent it from curing the infection.

What to do: Do not take these medications together because the hepatitis C treatment will not work correctly.

Antimycobacterial rifampin, rifapentine ↓ nirmatrelvir/ritonavir Co-administration contraindicated due to potential loss of virologic response and possible resistance.

Mechanism: Rifampin causes the body to break down nirmatrelvir/ritonavir too quickly, which lowers the amount of medicine in your blood. This can make the treatment less effective and may lead to the virus becoming resistant.

What to do: Do not take these two medications together.

Rifampin Clinical Impact: Rifampin significantly increases peak pitavastatin exposure and increases the risk of myopathy and rhabdomyolysis. Intervention: In patients taking rifampin, do not exceed pitavastatin tablets 2 mg once daily [see Dosage and Administration ( 2.4 )].

Mechanism: Rifampin causes the levels of pitavastatin in the blood to spike higher than they should. These high levels increase the chance of experiencing dangerous muscle injury.

What to do: If you are taking rifampin, your daily dose of pitavastatin should not exceed 2 mg.

Check all your medications →

Common Questions

Can rifampin change the color of my urine or other body fluids?
Yes, rifampin can cause your urine, sweat, saliva, and tears to turn reddish-orange.
Can I take rifampin with food?
It is best to take rifampin on an empty stomach, either 1 hour before or 2 hours after a meal.
What should I avoid while taking rifampin?
Avoid taking rifampin with other medicines that can harm your liver. Also, avoid alcohol.
Can rifampin interact with other medications?
Yes, rifampin can interact with many other medications. Tell your doctor about all the medicines you take.
What if I develop diarrhea while taking rifampin?
Tell your doctor right away if you develop diarrhea, especially if it is severe or bloody.
Can rifampin cause any vision problems?
Yes, rifampin can cause visual disturbances in some people. Tell your doctor if you notice any changes in your vision.
Are there any long-term side effects of rifampin?
In rare cases, rifampin can cause kidney problems or adrenal insufficiency with long-term use.
What happens if I take too much rifampin?
If you take too much rifampin, get medical help right away.
Can I stop taking rifampin when I feel better?
No, do not stop taking rifampin without talking to your doctor. Take it for the full course of treatment.
Who should not take rifampin?
You should not take rifampin if you are allergic to it or similar drugs, or if you are taking certain antiviral medications.
What are the common side effects of rifampin?
The most commonly reported side effects of rifampin include Heartburn, Upset stomach, Loss of appetite, Nausea, Vomiting. Based on 7,405 FDA adverse event reports. Always consult your healthcare provider about potential side effects.
Does rifampin interact with other medications?
Yes, rifampin has 137 known drug interactions. Notable interactions include darunavir, bictegravir/emtricitabine/tenofovir, glecaprevir/pibrentasvir. Always inform your doctor about all medications you are taking.
What drug class is rifampin?
rifampin belongs to the Rifamycin Antibiotic drug class. It requires a prescription (Rx). Rifampin treats tuberculosis (TB) and helps eliminate the bacteria that cause meningitis from your nose and throat.
Is rifampin safe during pregnancy?
Tell your doctor if you are pregnant or plan to become pregnant. Rifampin can make birth control pills less effective, so use other forms of birth control. Always consult your healthcare provider before using any medication during pregnancy or breastfeeding.
Has rifampin been recalled?
There are 2 recalls associated with rifampin products. CGMP Deviations: Firm went out of business and could no longer continue stability studies. Check the recalls section below for full details and affected products.
Is rifampin currently in shortage?
Yes, rifampin is currently listed as in shortage by the FDA. Affected manufacturer: Sanofi-Aventis U.S. LLC. Status: Available. Visit the FDA Drug Shortages database for the latest updates.

Active Recalls

Class II April 26, 2023

CGMP Deviations: Firm went out of business and could no longer continue stability studies.

Akorn, Inc.

Class II September 21, 2022

Failed impurities/degradation specifications: Finished product exceeds the 5 ppm interim limit for 1-Methyl-4-Nitrosopoperazine (MNP).

Akorn, Inc.

Related Medications in Rifamycin Antibiotic

Other drugs grouped near rifampin — same-class peers and common alternatives.

Compare rifampin vs amikacin side-by-side →

Medication Guides

Related Health & Safety Data

Save on rifampin

Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.

Disclosure: This link may earn us a commission at no extra cost to you. See our terms.

What the FDA Data Shows for rifampin

The FDA label for rifampin (sold under brand names such as Rifadin) classifies it as a prescription-only medication in the Rifamycin Antibiotic class. Rifampin treats tuberculosis (TB) and helps eliminate the bacteria that cause meningitis from your nose and throat. Official labeling lists 17 commonly reported side effects, including Heartburn, Upset stomach, Loss of appetite.

Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 7,405 voluntary reports. The database also lists 137 documented drug interactions derived from FDA labeling, with the top-flagged interaction rated major severity. NADAC pricing from CMS shows a generic unit cost of $0.60.

Report counts do not establish causation — a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history (currently 2 recall records on file), and patent information further shape supply and switching decisions. This page summarizes public FDA data for educational purposes only and is not a substitute for professional medical advice — always consult a licensed healthcare provider before starting, stopping, or changing any medication.

Data Sources

Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC). Shortage status: FDA Drug Shortages Database.

FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. Always consult a healthcare professional before making medication decisions.

Last updated: October 17, 2025

All federal data sources used on this page